Abstract
One of the main approaches in cheminformatics, so-called a quantitative structure-activity relationship (QSAR) approach, nowadays plays an important role in lead structure optimization, as well as in prediction of various physicochemical properties, biological activity, and environmental toxicology. One of the recent developments in QSAR approaches for nanostructures is a three-dimensional QSAR. For the last two decades, 3D-QSAR has already been successfully applied to various datasets, especially of enzyme and receptor ligands. The application of 3D-QSAR for nanostructured materials is still at early stage. Often, 3D-QSAR studies are going together with protein-ligand docking studies, and this combination works synergistically, improving the accuracy of prediction. Carbon nanostructures, such as fullerenes, and carbon nanotubes are nanomaterials with specific properties that make them useful in pharmacological applications. In this methodological review, we outline recent advances in development and application of 3D-QSAR and protein-ligand docking approaches in the studies of nanostructured materials, such as fullerenes and carbon nanotubes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hansch C, Leo A, Hoekman D, Leo A (1995) Exploring QSAR. American Chemical Society, Washington, DC
Kubinyi H (1997) QSAR and 3D QSAR in drug design part 1: methodology. Drug Discov Today 2(11):457–467
Kubinyi H (1997) QSAR and 3D QSAR in drug design part 2: applications and problems. Drug Discov Today 2(12):538–546
Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37(24):4130–4146
Karelson M, Lobanov VS, Katritzky AR (1996) Quantum-chemical descriptors in QSAR/QSPR studies. Chem Rev 96(3):1027–1044
Isayev O, Rasulev B, Gorb L, Leszczynski J (2006) Structure-toxicity relationships of nitroaromatic compounds. Mol Divers 10(2):233–245
Rasulev B, Toropov AA, Hamme AT II, Leszczynski J (2008) Multiple linear regression analysis and optimal descriptors: predicting the cholesteryl ester transfer protein inhibition activity. QSAR Comb Sci 27(5):595–606
Rasulev B, Kušić H, Leszczynska D, Leszczynski J, Koprivanac N (2010) QSAR modeling of acute toxicity on mammals caused by aromatic compounds: the case study using oral LD50 for rats. J Environ Monitor 12(5):1037–1044
Turabekova MA, Rasulev B, Dzhakhangirov FN, Leszczynska D, Leszczynski J (2010) Aconitum and Delphinium alkaloids of curare-like activity. QSAR analysis and molecular docking of alkaloids into AChBP. Eur J Med Chem 45(9):3885–3894
Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615–2623
Turabekova MA, Rasulev B, Dzhakhangirov FN, Salikhov SI (2008) Aconitum and Delphinium alkaloids. “Drug-likeness” descriptors related to toxic mode of action. Environ Toxicol Pharmacol 25:310–320
Toropov AA, Toropova AP, Rasulev B, Benfenati E, Gini G, Leszczynska D, Leszczynski J (2008) CORAL: binary classifications (active/inactive) for liver-related adverse effects of drugs. Curr Drug Saf 7(4):257–261
Ragno R, Artico M, De Martino G, La Regina G, Coluccia A, Di Pasquali A, Silvestri R (2005) Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl) carboxamide and N-(2-hydroxyethyl) carbohydrazide derivatives. J Med Chem 48(1):213–223
Hu R, Barbault F, Delamar M, Zhang R (2009) Receptor-and ligand-based 3D-QAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem 17(6):2400–2409
Sun J, Cai S, Yan N, Mei H (2010) Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis. Eur J Med Chem 45(3):1008–1014
Araújo JQ, de Brito MA, Hoelz LVB, de Alencastro RB, Castro HC, Rodrigues CR, Albuquerque MG (2011) Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE). Eur J Med Chem 46(1):39–51
Ahmed L, Rasulev B, Turabekova M, Leszczynska D, Leszczynski J (2013) Receptor-and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations. Org Biomol Chem 11(35):5798–5808
Jagiello K, Grzonkowska M, Swirog M, Ahmed L, Rasulev B, Avramopoulos A, Papadopoulos MG, Leszczynski J, Puzyn T (2016) Advantages and limitations of classic and 3D QSAR approaches in nano-QSAR studies based on biological activity of fullerene derivatives. J Nanopart Res 18(9):256
Wise M, Cramer RD, Smith D, Exman I (1983) Progress in three-dimensional drug design: the use of real-time colour graphics and computer postulation of bioactive molecules in DYLOMMS. Elsevier, Amsterdam
Cramer R, Bunce JD (1987) The DYLOMMS method: initial results from a comparative study of approaches to 3D QSAR. In: Hadzi D, Jerman-Blazic B (eds) QSAR in drug design and toxicology. Elsevier Science, Amsterdam, pp 3–12
Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110(18):5959–5967
Clark M, Cramer RD, Jones DM, Patterson DE, Simeroth PE (1990) Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Comput Methodol 3(1):47–59
Lill MA (2007) Multi-dimensional QSAR in drug discovery. Drug Discov Today 12(23):1013–1017
Kim KH, Greco G, Novellino E (1998) A critical review of recent CoMFA applications. In: Kubinyi H, Folkers G, Martin YC (eds) 3D QSAR in drug design. Springer, Dordrecht, pp 257–315
Todeschini R, Gramatica P (1998) 3D QSAR in drug design, vol 2. Kluwer/ESCOM, Dordrecht, pp 355–360
Podlogar BL, Ferguson DM (2000) QSAR and CoMFA: a perspective on the practical application to drug discovery. Drug Des Discov 17(1):4
Tripos (2006) SYBYL, version 7.3, 2006, St. Louis
Patel PD, Patel MR, Kaushik-Basu N, Talele TT (2008) 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors. J Chem Inf Model 48(1):42–55
Oprea TI, Matter H (2004) Integrating virtual screening in lead discovery. Curr Opin Chem Biol 8(4):349–358
Ahmed L, Rasulev B, Kar S, Krupa P, Mozolewska M, Leszczynski J (2017) Inhibitors or toxins? Large library target-specific screening of fullerene-based nanoparticles for drug design purpose. Nanoscale 9(29):10263–10276
Klebe G (2006) Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 11(13):580–594
Perola E (2006) Minimizing false positives in kinase virtual screens. Proteins: Struc Func Bioinf 64(2):422–435
Pajeva IK, Globisch C, Wiese M (2009) Combined pharmacophore modeling, docking, and 3D QSAR studies of ABCB1 and ABCC1 transporter inhibitors. ChemMedChem 4(11):1883–1896
Yang S-Y (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15(11):444–450
Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28(7):849–857
Kim KH (2001) Thermodynamic aspects of hydrophobicity and biological QSAR. J Comput Aid Mol Des 15(4):367–380
Hopfinger AJ (1980) A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis. J Am Chem Soc 102(24):7196–7206
Doweyko AM (1988) The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules. J Med Chem 31(7):1396–1406
Walters DE, Hinds RM (1994) Genetically evolved receptor models: a computational approach to construction of receptor models. J Med Chem 37(16):2527–2536
Pastor M, Cruciani G, McLay I, Pickett S, Clementi S (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43:3233–3243
Fontaine F, Pastor M, Zamora I, Sanz F (2005) Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. J Med Chem 48(7):2687–2694
Fontaine F, Pastor M, Sanz F (2004) Incorporating molecular shape into the alignment-free GRid-INdependent descriptors. J Med Chem 47(11):2805–2815
Silverman B, Platt DE (1996) Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. J Med Chem 39(11):2129–2140
Ortiz AR, Pisabarro MT, Gago F, Wade RC (1995) Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 38(14):2681–2691
Polanski J, Gieleciak R, Bak A (2002) The comparative molecular surface analysis (CoMSA)-a nongrid 3D QSAR method by a coupled neural network and PLS system: predicting pKa values of benzoic and alkanoic acids. J Chem Inf Comput Sci 42(2):184–191
Polanski J, Bak A, Gieleciak R, Magdziarz T (2006) Modeling robust QSAR. J Chem Inf Model 46(6):2310–2318
Datar PA, Khedkar SA, Malde AK, Coutinho EC (2006) Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands. J Comput Aid Mol Des 20(6):343–360
Dhaked DK, Verma J, Saran A, Coutinho EC (2009) Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA). J Mol Model 15(3):233–245
Robinson DD, Winn PJ, Lyne PD, Richards WG (1999) Self-organizing molecular field analysis: a tool for structure-activity studies. J Med Chem 42(4):573–583
Zhou P, Tian F, Li Z (2007) Three-dimensional holographic vector of atomic interaction field (3D-HoVAIF). Chemom Intell Lab Syst 87(1):88–94
Ajmani S, Jadhav K, Kulkarni SA (2006) Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. J Chem Inf Model 46(1):24–31
Baskin II, Zhokhova NI (2013) The continuous molecular fields approach to building 3D-QSAR models. J Comput Aid Mol Des 27(5):427–442
Zhokhova NI, Baskin II, Bakhronov DK, Palyulin VA, Zefirov NS (2009) Method of continuous molecular fields in the search for quantitative structure-activity relationships. Dokl Chem 429(1):273–276
Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development and 3D database screening. 1. Methodology and preliminary results. J Comput Aid Mol Des 20:647–671
Totrov M (2008) Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR. Chem Biol Drug Des 71(1):15–27
Li H, Sutter J, Hoffmann R (2000) HypoGen: an automated system for generating 3D predictive pharmacophore models. In: Gﺴner OF (ed) Pharmacophore perception, development, and use in drug design (pp. 171–189). International University Line, La Jolla, Calif, USA
Evans DA, Doman TN, Thorner DA, Bodkin MJ (2007) 3D QSAR methods: phase and catalyst compared. J Chem Inf Model 47(3):1248–1257
Durdagi S, Mavromoustakos T, Chronakis N, Papadopoulos MG (2008a) Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Bioorg Med Chem 16(23):9957–9974
Durdagi S, Mavromoustakos T, Papadopoulos MG (2008b) 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Bioorg Med Chem Lett 18(23):6283–6289
Durdagi S, Supuran CT, Strom TA, Doostdar N, Kumar MK, Barron AR, Mavromoustakos T, Papadopoulos MG (2009) In silico drug screening approach for the design of magic bullets: a successful example with anti-HIV fullerene derivatized amino acids. J Chem Inf Model 49(5):1139–1143
Tzoupis H, Leonis G, Durdagi S, Mouchlis V, Mavromoustakos T, Papadopoulos MG (2011) Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson–Boltzmann surface area calculations. J Comput Aid Mol Des 25(10):959–976
Calvaresi M, Zerbetto F (2010) Baiting proteins with C60. ACS Nano 4(4):2283–2299
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acid Res 33:W363–W367
Calvaresi M, Zerbetto F (2011) Fullerene sorting proteins. Nanoscale 3(7):2873–2881
Ghasemi JB, Salahinejad M, Rofouei MK (2013) Alignment independent 3D-QSAR modeling of fullerene (C60) solubility in different organic solvents. Fuller Nanotub Car N 21(5):367–380
Rofouei MK, Salahinejad M, Ghasemi JB (2014) An alignment independent 3D-QSAR modeling of dispersibility of single-walled carbon nanotubes in different organic solvents. Fuller Nanotub Car N 22(7):605–617
Esposito EX, Hopfinger AJ, Shao CY, Su BH, Chen SZ, Tseng YJ (2015) Exploring possible mechanisms of action for the nanotoxicity and protein binding of decorated nanotubes: interpretation of physicochemical properties from optimal QSAR models. Toxicol Appl Pharmacol 288(1):52–62
Saikia N, Rajkhowa S, Deka RC (2013) Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein. J Comput Aid Mol Des 27(3):257–276
Turabekova M, Rasulev B, Theodore M, Jackman J, Leszczynska D, Leszczynski J (2014) Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C 60 fullerenes might be recognized as pathogens by Toll-like receptors. Nanoscale 6(7):3488–3495
Mozolewska MA, Krupa P, Rasulev B, Liwo A, Leszczynski J (2014) Preliminary studies of interaction between nanotubes and toll-like receptors. Task Quarterly 18(4):351–355
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rasulev, B. (2020). Ecotoxicological QSAR Modeling of Nanomaterials: Methods in 3D-QSARs and Combined Docking Studies for Carbon Nanostructures. In: Roy, K. (eds) Ecotoxicological QSARs. Methods in Pharmacology and Toxicology. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0150-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0150-1_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0149-5
Online ISBN: 978-1-0716-0150-1
eBook Packages: Springer Protocols